{"id":"W3200389877","doi":"10.1055/a-1653-4699","title":"Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial","year":2021,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Bayer Vital; Novartis Pharma; LEO Pharma; Servier; ZonMw; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Boston Scientific Corporation; Acceleron; Ministerio de Ciencia e Innovación; Novo Nordisk; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; United Therapeutics Corporation; Bayer; Bristol-Myers Squibb; AstraZeneca; Pfizer; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Thrombolysis; Decompensation; Pulmonary embolism; Cardiology; Hemodynamics; Myocardial infarction; Internal medicine; Pulmonary hypertension; Anesthesia","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007882757,0.0005977332,0.001829676,0.0002871088,0.0006194199,0.000171027,0.0004218015,0.0003075862,0.000396731],"category_scores_gemma":[0.0003337719,0.0004733824,0.0005219534,0.0005957183,0.0005532592,0.0003484807,0.0006182544,0.0003772803,0.000007049425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001248406,"about_ca_system_score_gemma":0.0003212242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002751114,"about_ca_topic_score_gemma":0.00003641694,"domain_scores_codex":[0.996022,0.0003316022,0.001118664,0.00109345,0.0008123099,0.0006219996],"domain_scores_gemma":[0.9970747,0.0005049823,0.0006444015,0.0009337035,0.0005523241,0.0002898931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02859273,0.02295033,0.01208639,0.00220568,0.04670501,0.0004015358,0.01806492,0.0006462412,0.1627246,0.0320475,0.03126623,0.6423089],"study_design_scores_gemma":[0.05366071,0.002535229,0.8197016,0.001192329,0.02692185,0.0004717719,0.00658069,0.005907893,0.05968576,0.01274525,0.008455933,0.002141043],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802194,0.001614668,0.002269561,0.009148752,0.00157766,0.003603046,0.0008892496,0.00008786064,0.0005898509],"genre_scores_gemma":[0.958287,0.03211335,0.006129839,0.001134875,0.0007572394,0.000619958,0.0004376308,0.0001143406,0.0004057586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8076152,"threshold_uncertainty_score":0.9997718,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04047820421835464,"score_gpt":0.3078143625059836,"score_spread":0.267336158287629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}